{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T21:24:07Z","timestamp":1770931447715,"version":"3.50.1"},"reference-count":7,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004191","name":"Novo Nordisk","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004191","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["canadianjournalofdiabetes.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Canadian Journal of Diabetes"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.jcjd.2025.10.170","type":"journal-article","created":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T14:20:44Z","timestamp":1760538044000},"page":"15-22.e5","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Real-world Impact of Type 2 Diabetes Mellitus in Employer-sponsored Benefit Plans"],"prefix":"10.1016","volume":"50","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-8982-7558","authenticated-orcid":false,"given":"Godfrey","family":"Mau","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8187-7047","authenticated-orcid":false,"given":"Julie Hviid","family":"Hahn-Pedersen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcjd.2025.10.170_bib4","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1472-6963-3-7","article-title":"Cost of managing complications resulting from type 2 diabetes mellitus in Canada","volume":"3","author":"O\u2019Brien","year":"2003","journal-title":"BMC Health Serv Res"},{"key":"10.1016\/j.jcjd.2025.10.170_bib7","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.2337\/dci19-0017","article-title":"Understanding the economic costs of diabetes and prediabetes and what we may learn about reducing the health and economic burden of these conditions","volume":"42","author":"O\u2019Connell","year":"2019","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jcjd.2025.10.170_bib8","doi-asserted-by":"crossref","first-page":"26","DOI":"10.2337\/dci23-0085","article-title":"Economic costs of diabetes in the U.S. in 2022","volume":"47","author":"Parker","year":"2024","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jcjd.2025.10.170_bib9","article-title":"Burnout related to diabetes mellitus: A critical analysis","volume":"18","author":"Kontoangelos","year":"2022","journal-title":"Crit Pract Epidemiol Ment Health"},{"key":"10.1016\/j.jcjd.2025.10.170_bib10","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.ando.2022.12.423","article-title":"Dual GIP\/GLP-1 receptor agonists: New advances for treating type-2 diabetes","volume":"84","author":"Scheen","year":"2023","journal-title":"Ann Endocrinol"},{"key":"10.1016\/j.jcjd.2025.10.170_bib11","doi-asserted-by":"crossref","first-page":"464","DOI":"10.2337\/diacare.25.3.464","article-title":"Comorbid depression is associated with increased health care use and expenditures in individuals with diabetes","volume":"25","author":"Egede","year":"2002","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jcjd.2025.10.170_bib12","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.jcjd.2023.04.009","article-title":"Diabetes and mental health","volume":"47","year":"2023","journal-title":"Can J Diabetes"}],"container-title":["Canadian Journal of Diabetes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1499267125003508?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1499267125003508?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T20:53:40Z","timestamp":1770929620000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1499267125003508"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":7,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["S1499267125003508"],"URL":"https:\/\/doi.org\/10.1016\/j.jcjd.2025.10.170","relation":{},"ISSN":["1499-2671"],"issn-type":[{"value":"1499-2671","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Real-world Impact of Type 2 Diabetes Mellitus in Employer-sponsored Benefit Plans","name":"articletitle","label":"Article Title"},{"value":"Canadian Journal of Diabetes","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcjd.2025.10.170","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Diabetes Canada.","name":"copyright","label":"Copyright"}]}}